...
机译:Alarmin Interleukin-33驱动保护性抗病毒CD8〜+ T细胞反应
Department of Pathology and Immunology, University of Geneva, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,World Health Organization Collaborating Center for Vaccine Immunology, University of Geneva, Switzerland;
Experimental Immunology, Department of Rheumatology and Clinical Immunology, Charite-University Medicine Berlin, Berlin, Germany,German Rheumatism Research Center (DRFZ), a Leibniz Institute, Charite'platz 1, 10117 Berlin, Germany;
Institute for Cancer Research, Department of Pathology, University Hospital of Zurich, Schmelzbergstrasse 12, 8091 Zurich, Switzerland;
Department of Pathology and Immunology, University of Geneva, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,World Health Organization Collaborating Center for Vaccine Immunology, University of Geneva, Switzerland;
Department of Pathology and Immunology, University of Geneva, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,World Health Organization Collaborating Center for Vaccine Immunology, University of Geneva, Switzerland;
Department of Pathology and Immunology, University of Geneva, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,World Health Organization Collaborating Center for Vaccine Immunology, University of Geneva, Switzerland;
Department of Pathology and Immunology, University of Geneva, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,Division of Clinical Pathology, Geneva University Hospital, 1 rue Michel Servet, 1211 Geneva 4, Switzerland;
Experimental Immunology, Department of Rheumatology and Clinical Immunology, Charite-University Medicine Berlin, Berlin, Germany,German Rheumatism Research Center (DRFZ), a Leibniz Institute, Charite'platz 1, 10117 Berlin, Germany,Department of Gastroenterology, Hepatology and Endocrinology, Campus Charite Mitte, Charite-University Medicine Berlin, Berlin, Germany;
Department of Pathology and Immunology, University of Geneva, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,Division of Clinical Pathology, Geneva University Hospital, 1 rue Michel Servet, 1211 Geneva 4, Switzerland;
Institute of Molecular Medicine, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland;
Institute for Cancer Research, Department of Pathology, University Hospital of Zurich, Schmelzbergstrasse 12, 8091 Zurich, Switzerland;
The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, and Japan Science and Technology Agency,Precursory Research for Embryonic Science and Technology(PRESTO), 4-1-8 Hncho, Kawaguchi, Saitama 332-0012, Japan;
Helmholtz Zentrum Munchen, Institute of Molecular Immunology and Clinical Cooperation Group Hematopoietic Cell Transplantation (CCG HCD, Marchioninistrasse 25, 81377 Munchen,Germany;
Department of Pathology and Immunology, University of Geneva, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,Division of Clinical Pathology, Geneva University Hospital, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,Department of Neuropathology, University Medical Center, Georg August University, Goettingen, Germany;
Experimental Immunology, Department of Rheumatology and Clinical Immunology, Charite-University Medicine Berlin, Berlin, Germany,German Rheumatism Research Center (DRFZ), a Leibniz Institute, Charite'platz 1, 10117 Berlin, Germany;
Department of Pathology and Immunology, University of Geneva, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,World Health Organization Collaborating Center for Vaccine Immunology, University of Geneva, Switzerland;
机译:补体C5a通过Peyer的贴剂单核细胞衍生的树突细胞促进抗原交叉呈递,并驱动保护CD8T≥细胞反应
机译:呼吸道合胞病毒CTL肽与肠毒素的佐剂的粘膜递送引起保护性,免疫致病性和免疫调节性抗病毒CD8〜+ T细胞反应。
机译:呼吸道合胞病毒CTL肽与肠毒素类佐剂的粘膜递送可引起保护性,免疫致病性和免疫调节性抗病毒CD8 + T细胞反应。
机译:T1D相关的LNCRNA调节I型干扰素信号传导和胰腺β细胞中的抗病毒反应。
机译:细胞介导的抗病毒免疫和宿主对CD8 T细胞疫苗和呼吸道病毒感染的反应。
机译:SIVΔnef的持久性低水平复制驱动抗体和CD8 T细胞应答的成熟从而诱导针对阴道SIV感染的保护性免疫。
机译:警报白细胞介素-33驱动保护抗病毒CD8 + T细胞应答